Oncology & Cancer

New antibody therapies fight cancer, drum up investment

Antibody therapies are offering promising treatment breakthroughs for cancer and other illnesses, generating greater investor interest more than 20 years after they were first commercialized.

Immunology

Antibodies point researchers toward broad coronavirus vaccines

Scientists at Johns Hopkins University and Scripps Research have characterized 30 antibodies that recognize a wide range of coronaviruses—successfully blocking not only all the SARS-CoV-2 variants that were tested but also ...

Diseases, Conditions, Syndromes

Study shines light on longevity of COVID-19 immune response

By uniting research from eight cohorts across the U.S., a group of researchers has accelerated collection of data integral in answering questions about immune responses needed for long lasting protection from SARS-CoV-2. ...

Diseases, Conditions, Syndromes

Studies reveal key clues about COVID-19 immunity, immune recall

How does the immune system remember and recognize viral invaders it has encountered in the past? A trio of newly published studies of people infected with SARS-CoV-2, vaccinated against the virus, or both are providing tantalizing ...

Pediatrics

Q and A: A parents' guide to COVID booster shots for kids 5-11

With COVID-19 cases rising again in the Bay Area, parents have a new consideration for protecting their children this week: The Food and Drug Administration granted emergency use authorization Tuesday for kids ages 5-11 to ...

page 6 from 40